Invention Grant
- Patent Title: Hybridoma clones and monoclonal antibodies to CD9
-
Application No.: US14776420Application Date: 2014-03-17
-
Publication No.: US09862773B2Publication Date: 2018-01-09
- Inventor: David Azorsa
- Applicant: The Translational Genomics Research Institute
- Applicant Address: US AZ Phoenix
- Assignee: The Translational Genomics Research Institute
- Current Assignee: The Translational Genomics Research Institute
- Current Assignee Address: US AZ Phoenix
- International Application: PCT/US2014/030797 WO 20140317
- International Announcement: WO2014/145940 WO 20140918
- Main IPC: C12N5/20
- IPC: C12N5/20 ; C07K16/00 ; C07K16/28 ; C07K17/00 ; G01N33/53
Abstract:
The present invention is directed to a monoclonal antibody that recognizes human CD9 in its native form. The invention is also directed to a hybridoma cell line that produces the monoclonal antibody, and exosome isolation kits using the antibody.
Public/Granted literature
- US20160032002A1 Hybridoma Clones and Monoclonal Antibodies to CD9 Public/Granted day:2016-02-04
Information query
IPC分类:
